Par Drugs And Chemicals Limited (PAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs80.95 Million ≈ $875.41K USD) by net assets (Rs1.06 Billion ≈ $11.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Par Drugs And Chemicals Limited (PAR) net asset quality to measure how much of total assets are equity-financed.
Par Drugs And Chemicals Limited - Cash Flow Conversion Efficiency Trend (2016–2026)
This chart illustrates how Par Drugs And Chemicals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Par Drugs And Chemicals Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Par Drugs And Chemicals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Par Drugs And Chemicals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NPK Co.Ltd
KQ:048830
|
0.058x |
|
Phapros Tbk PT
JK:PEHA
|
0.064x |
|
Alliance Nickel Ltd
AU:AXN
|
-0.021x |
|
Imexhs Ltd
AU:IME
|
-0.103x |
|
Berkah Beton Sadaya Tbk PT
JK:BEBS
|
0.001x |
|
New Age Metals Inc
V:NAM
|
-0.029x |
|
Dadi Early-Childhood Education Group Ltd
TWO:8437
|
-0.001x |
|
TRANSTEMA GROUP AB O.N.
F:9G8
|
0.059x |
Annual Cash Flow Conversion Efficiency for Par Drugs And Chemicals Limited (2016–2026)
The table below shows the annual cash flow conversion efficiency of Par Drugs And Chemicals Limited from 2016 to 2026. For the full company profile with market capitalisation and key ratios, see how much is Par Drugs And Chemicals Limited worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs1.12 Billion ≈ $12.11 Million |
Rs164.32 Million ≈ $1.78 Million |
0.147x | -10.13% |
| 2025-03-31 | Rs989.75 Million ≈ $10.70 Million |
Rs161.60 Million ≈ $1.75 Million |
0.163x | -30.95% |
| 2024-03-31 | Rs856.32 Million ≈ $9.26 Million |
Rs202.49 Million ≈ $2.19 Million |
0.236x | +25.93% |
| 2023-03-31 | Rs712.38 Million ≈ $7.70 Million |
Rs133.77 Million ≈ $1.45 Million |
0.188x | +47.65% |
| 2022-03-31 | Rs598.77 Million ≈ $6.48 Million |
Rs76.15 Million ≈ $823.55K |
0.127x | -45.05% |
| 2021-03-31 | Rs522.15 Million ≈ $5.65 Million |
Rs120.85 Million ≈ $1.31 Million |
0.231x | +22.22% |
| 2020-03-31 | Rs406.15 Million ≈ $4.39 Million |
Rs76.91 Million ≈ $831.77K |
0.189x | -27.23% |
| 2019-03-31 | Rs291.17 Million ≈ $3.15 Million |
Rs75.77 Million ≈ $819.45K |
0.260x | +24.73% |
| 2018-03-31 | Rs206.99 Million ≈ $2.24 Million |
Rs43.18 Million ≈ $467.01K |
0.209x | -56.32% |
| 2017-03-31 | Rs192.03 Million ≈ $2.08 Million |
Rs91.72 Million ≈ $991.96K |
0.478x | +27.00% |
| 2016-03-31 | Rs173.56 Million ≈ $1.88 Million |
Rs65.27 Million ≈ $705.91K |
0.376x | -- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more